N-α-Fmoc-N-δ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-ornithine

N-α-Fmoc-N-δ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-ornithine is an Fmoc-protected L-ornithine derivative in which the α-amino group is masked for solid-phase peptide synthesis compatibility, while the δ-side-chain amino functionality is converted into a substituted amidine/guanidinium-like motif bearing a 4,4-dimethyl-2,6-dioxocyclohex-1-ylidene substituent. The molecule retains the L-ornithine stereochemistry at the α-carbon and presents a protected, conformationally constrained side-chain element that can influence ionic character and hydrogen-bonding patterns during peptide assembly and downstream transformations. The δ-substituent includes two carbonyl-bearing positions within a cyclohexanedione-derived framework, providing defined electrophilic/acid-base behavior and a handle for controlled deprotection or functional conversion under peptide-manufacturing conditions. The resulting chiral amino acid building block is suited to peptide coupling chemistry through its Fmoc-protected α-amino group and can serve as a chemically encoded intermediate for side-chain functionalization and peptidomimetic scaffold construction.

1. Peptide Synthesis

N-α-Fmoc-N-δ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-ornithine is applied in peptide synthesis workflows where an Fmoc-protected amino acid building block is required for stepwise N-terminal assembly. The Fmoc group enables orthogonal deprotection strategies that expose the α-amino nucleophile for peptide coupling while keeping the δ-side-chain functionality protected in a form that can modulate reactivity and solubility. The L-ornithine backbone provides a side-chain length and stereodefined geometry typical of arginine/ornithine-derived peptide motifs, while the δ-substituent introduces carbonyl-rich functionality that can be carried through coupling steps and later converted to new side-chain chemistries. The compound can therefore be used to prepare peptide analogs and constrained peptidomimetics in which side-chain hydrogen-bonding and polarity are tuned through a defined protected group strategy.

2. Chemical Biology Probes

N-α-Fmoc-N-δ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-ornithine supports chemical biology research by providing an amino acid-derived handle for controlled modification of peptide and protein scaffolds. The δ-side-chain protected functionality, together with the cyclohexanedione-derived carbonyl system, can function as a masked reactive motif that may undergo subsequent transformation to generate conjugation-ready groups or to introduce defined polar features into biomolecule-bound ligands. The presence of the stereochemically defined L-ornithine center helps preserve recognition-relevant conformations when incorporated into peptide probes. The Fmoc-protected α-amino group allows integration into longer sequences during probe synthesis, enabling downstream labeling, affinity tag installation, or mechanistic studies that rely on side-chain-specific chemistry rather than backbone-level changes.

3. Peptidomimetics And SAR

N-α-Fmoc-N-δ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-ornithine is suitable for peptidomimetic construction and structure-activity relationship studies where side-chain polarity and hydrogen-bonding capacity are key design variables. The δ-substituent introduces a carbonyl-rich, conformationally informative fragment that can alter local electrostatics and potential intramolecular interactions compared with unmodified ornithine analogs. The protected amino acid format supports systematic library synthesis by enabling consistent incorporation into peptide-like backbones while keeping reactive functionalities masked until the desired stage of synthesis. The resulting analogs can be used to generate SAR datasets that correlate side-chain-derived physicochemical changes with binding or functional readouts in biochemical assay systems, while maintaining stereochemical fidelity to the L-ornithine framework.

4. Protected Amino Acid Intermediates

N-α-Fmoc-N-δ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-ornithine functions as a protected amino acid intermediate for downstream synthetic routes that require orthogonal protection of α- and δ-nitrogen functionalities. The Fmoc group provides a removable N-terminal protecting strategy compatible with common peptide coupling and deprotection chemistries, while the δ-side-chain masking group is engineered to withstand peptide assembly conditions and to enable later conversion to alternative side-chain chemistries. The cyclohexanedione-derived substituent adds carbonyl functionality that can be leveraged for controlled derivatization, including formation of new amide-like or heteroatom-containing motifs depending on the synthetic sequence. This intermediate utility supports fine chemical synthesis planning for chiral building blocks, including the preparation of substituted ornithine derivatives used in peptide analog manufacturing and specialized molecular scaffold generation.

5. Pharmaceutical Manufacturing Intermediates

N-α-Fmoc-N-δ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-ornithine is relevant to pharmaceutical manufacturing and process chemistry for the production of protected peptide building blocks and defined peptidomimetic intermediates. The Fmoc-protected α-amino group supports scalable peptide coupling strategies in which controlled deprotection exposes a single reactive site for N-acylation, reducing side reactions from unprotected amines. The δ-side-chain protection strategy can be used to manage functional-group compatibility during multistep synthesis, particularly when carbonyl-rich motifs must remain intact through coupling and purification operations. The stereodefined L-ornithine core aids in maintaining chiral integrity across manufacturing stages, enabling consistent downstream formation of sequence-defined intermediates for bulk peptide or peptide-analog production. The compound thus serves as a chemically coherent input for industrial peptide synthesis planning where orthogonality, functional group stability, and chiral fidelity are required.

6. Analytical Standards And Method Development

N-α-Fmoc-N-δ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-ornithine can be employed in analytical research and method development as a structurally defined amino acid derivative standard. The combination of Fmoc chromophore character and the carbonyl-rich δ-substituent provides distinct mass spectrometric and chromatographic signatures that assist in monitoring protected amino acid integrity, partial deprotection, and side-chain transformation during peptide synthesis workflows. The L-ornithine stereochemistry and defined substitution pattern enable unambiguous identification of chiral building blocks and related impurities in process development studies. The compound's defined functional-group set also supports method validation for assays tracking derivatization efficiency and intermediate formation in peptide manufacturing and fine chemical synthesis.

1. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

2. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

4. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

5. High fat diet and GLP-1 drugs induce pancreatic injury in mice